NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Methode Electronics, Inc. (“Methode Electronics” or the “Company”) (NYSE: MEI) for violations of the federal securities laws on behalf of investors who purchased or […]

LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) securities between February 22,

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=103892&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Super Micro Computer, Inc. (NASDAQ:SMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/super-micro-computer-inc-lawsuit-submission-form?prid=103891&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Methode Electronics, Inc. (NYSE:MEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/methode-electronics-inc-lawsuit-submission-form?prid=103890&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sage-therapeutics-lawsuit-submission-form?prid=103889&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are

LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired DXC Technology Company (“DXC” or the “Company”) (NYSE: DXC) common stock between

LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 15, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired PDD Holdings Inc. (“PDD” or the “Company”) (NASDAQ: PDD) securities between April

Motion, the creative analytics and research platform used by creative strategists, announced today that it has secured $30 million USD in Series B funding led by Inovia with participation from Threshold Ventures as well as existing investors Headline, Abstract Ventures, and Sugar Capital. The funding will accelerate Motion’s product roadmap and deepen its analytics and